CS logo
small CS logo
Centralia Oncology Clinic

Centralia, Illinois, United States
Cancer treatment center in Centralia, Illinois
1052 M.L.K. Jr Dr #2, Centralia, IL 62801

About Centralia Oncology Clinic


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
110
SWOG Cancer Research Network
50
Alliance for Clinical Trials in Oncology
39
ECOG-ACRIN Cancer Research Group
22
NRG Oncology
9
Wake Forest University Health Sciences
5
Children's Oncology Group
3
GOG Foundation
3
Gynecologic Oncology Group
3
Eastern Cooperative Oncology Group
2
NSABP Foundation Inc
1
Total Rows: 13

Clinical Trials at Centralia Oncology Clinic


During the past decade, Centralia Oncology Clinic conducted 170 clinical trials. In the 10-year time frame, 170 clinical trials started and 85 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 56 clinical trials started and 62 clinical trials were completed. i.e. 110.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years212117172323222231313232212133003333551212151522221919Started TrialsCompleted Trails2015201620172018201920202021202202040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403

Rows per page:

1–100 of 249

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Centralia Oncology Clinic" #1 sponsor was "National Cancer Institute (NCI)" with 110 trials, followed by "SWOG Cancer Research Network" with 50 trials sponsored, "Alliance for Clinical Trials in Oncology" with 39 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 22 trials sponsored and "NRG Oncology" with 22 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centralia Oncology Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 136 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 110National CancerInstitute (NCI): 110SWOG Cancer ResearchNetwork: 50SWOG Cancer ResearchNetwork: 50Alliance for ClinicalTrials in Oncology: 39Alliance for ClinicalTrials in Oncology: 39ECOG-ACRIN CancerResearch Group: 22ECOG-ACRIN CancerResearch Group: 22NRG Oncology: 9NRG Oncology: 9Wake Forest UniversityHealth Sciences: 5Wake Forest UniversityHealth Sciences: 5Children's Oncology Group: 3Children's Oncology Group: 3GOG Foundation: 3GOG Foundation: 3Gynecologic Oncology Group: 3Gynecologic Oncology Group: 3Eastern CooperativeOncology Group: 2Eastern CooperativeOncology Group: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 136National CancerInstitute (NCI): 136NRG Oncology: 23NRG Oncology: 23Canadian Cancer TrialsGroup: 11Canadian Cancer TrialsGroup: 11MillenniumPharmaceuticals, Inc.: 3MillenniumPharmaceuticals, Inc.: 3AstraZeneca: 2AstraZeneca: 2Agenus Inc.: 1Agenus Inc.: 1Astellas Pharma US, Inc.: 1Astellas Pharma US, Inc.: 1Bayer: 1Bayer: 1Biologics, Inc.: 1Biologics, Inc.: 1Brain Science Foundation: 1Brain Science Foundation: 1

Clinical Trials Conditions at Centralia Oncology Clinic


According to Clinical.Site data, the most researched conditions in "Centralia Oncology Clinic" are "Stage IV Lung Cancer AJCC v8" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Invasive Breast Carcinoma" (9 trials), "Recurrent Lung Non-Small Cell Carcinoma" (9 trials) and "Recurrent Ovarian Carcinoma" (8 trials). Many other conditions were trialed in "Centralia Oncology Clinic" in a lesser frequency.

Clinical Trials Intervention Types at Centralia Oncology Clinic


Most popular intervention types in "Centralia Oncology Clinic" are "Drug" (190 trials), "Other" (155 trials), "Biological" (98 trials), "Procedure" (68 trials) and "Radiation" (35 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (65 trials), "Quality-of-Life Assessment" (60 trials), "Questionnaire Administration" (48 trials), "Biospecimen Collection" (38 trials) and "Computed Tomography" (37 trials). Other intervention names were less common.

Clinical Trials Genders at Centralia Oncology Clinic


The vast majority of trials in "Centralia Oncology Clinic" are 209 trials for "All" genders, 36 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at Centralia Oncology Clinic


Currently, there are NaN active trials in "Centralia Oncology Clinic". undefined are not yet recruiting, 80 are recruiting, 108 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Centralia Oncology Clinic, 9 suspended trials, and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Centralia Oncology Clinic, 10 "Phase 1" clinical trials were conducted, 129 "Phase 2" clinical trials and 119 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 129Phase 2: 129Phase 3: 119Phase 3: 119Phase 1: 10Phase 1: 10Not Applicable: 7Not Applicable: 7Early Phase 1: 1Early Phase 1: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 108Active, not recruiting: 108Recruiting: 80Recruiting: 80Completed: 42Completed: 42Suspended: 9Suspended: 9Terminated: 9Terminated: 9Unknown status: 1Unknown status: 1